Adsorption of human blood plasma on nanodiamond and its influence on activated partial thromboplastin time

被引:29
|
作者
Mona, J. [1 ]
Kuo, C-J [1 ]
Perevedentseva, E. [1 ,2 ]
Priezzhev, A. V. [3 ]
Cheng, C. -L. [1 ]
机构
[1] Natl Dong Hwa Univ, Dept Phys, Shoufeng 97401, Hualien, Taiwan
[2] Rus Acad Sci, PN Lebedev Phys Inst, Moscow 119991, Russia
[3] Moscow MV Lomonosov State Univ, Dept Phys, Ctr Int Laser, Moscow 119991, Russia
关键词
Nanodiamond; Human blood plasma; Adsorption; Blood coagulation; FLUORESCENT NANODIAMONDS; PROTEIN ADSORPTION; CARBON NANOTUBES; DIAMOND; NANOPARTICLES; PLATELETS;
D O I
10.1016/j.diamond.2013.08.001
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Ever increasing use of engineered nanodiamond (ND) into the human blood for various biomedical studies and applications has increased the demand to thoroughly understand the interaction of NDs with blood and its effect on blood coagulation. Here, we report on the study of adsorption of human blood plasma on various sized carboxylated nanodiamonds (cNDs) using UV/visible spectroscopy and Fourier transform infrared spectroscopy (FIR). The adsorption of human blood plasma on 5 nm and 100 nm sized cNDs is confirmed from UV/visible spectra. FTIR shows minor change in the shape of amide 1 absorption peak (1600-1700 cm(-1)) indicating that the protein secondary structure remains unaffected for human blood plasma. The influence of cNDs on the blood coagulation has been estimated using Activated Partial Thromboplastin Time (APTT) test. The APTT test is one of the standard tests used to investigate the efficacy of the intrinsic pathways of coagulation. The APTT test results indicate that 5 and 100 nm cNDs with various concentrations (10-500 mu g/ml) do not show delay in time when coagulation was initiated through the intrinsic pathway. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
  • [1] Correlation of whole blood activated partial thromboplastin time and plasma activated partial thromboplastin time in haemodialysis patients
    Low, CL
    Eisele, G
    Bailie, GR
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (12) : 2523 - 2523
  • [2] ACTIVATED PARTIAL THROMBOPLASTIN TIME PERFORMED ON CAPILLARY BLOOD
    BOUMERFEG, M
    AUROUSSEAU, MH
    LEROUX, G
    LORTHOLARY, P
    [J]. NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1989, 31 (05): : 359 - 361
  • [3] INFLUENCE OF AGE, SEX AND ABO BLOOD-GROUP ON ACTIVATED PARTIAL THROMBOPLASTIN TIME
    FOUREL, V
    GABASTOU, JM
    DUROURE, FD
    EHRHARDT, N
    ROBERT, A
    [J]. HAEMOSTASIS, 1993, 23 (06) : 321 - 326
  • [4] THE ACTIVATED PARTIAL THROMBOPLASTIN TIME
    FRANCIS, RB
    [J]. ANNALS OF INTERNAL MEDICINE, 1986, 105 (04) : 626 - 626
  • [5] THE ACTIVATED PARTIAL THROMBOPLASTIN TIME
    BASHEVKIN, ML
    NAWABI, IU
    [J]. ANNALS OF INTERNAL MEDICINE, 1986, 105 (03) : 470 - 470
  • [6] Activated partial thromboplastin time
    Lozano, MIguel
    Mazzara, Roberto
    [J]. MEDICINA CLINICA, 2007, 128 (11): : 438 - 439
  • [7] Activated partial thromboplastin time
    Rodgers, GM
    [J]. LABORATORY MEDICINE, 1999, 30 (10) : 640 - 640
  • [8] Effect of dabigatran spiked to human plasma on various activated partial thromboplastin time methods
    Harenberg, J.
    Giese, C.
    Marx, S.
    Weiss, C.
    Kraemer, R.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 364 - 364
  • [9] ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASUREMENTS IN CITRATED CANINE PLASMA
    EVANS, GO
    FLYNN, RM
    [J]. JOURNAL OF COMPARATIVE PATHOLOGY, 1992, 106 (01) : 79 - 82
  • [10] THE EFFECT OF CALCIUM ON THE ACTIVATED PARTIAL THROMBOPLASTIN TIME OF HEPARINIZED PLASMA
    GREENBERG, CS
    ADAMS, JP
    KOEPKE, JA
    [J]. THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 295 - 295